Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 16Unknown 4Terminated 3Withdrawn 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 5Leukemia 4Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Neoplasm, Residual 1Leukemia, Myeloid, Accelerated Phase 1Graft vs Host Disease 1

Interventions

Idarubicin 2Cytarabine 2fludarabine phosphate 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Isotretinoin 1Interferon-alpha 1Idoxuridine 1Drug Therapy 1Bromodeoxyuridine 1Biological Therapy 1BI 6727 1Arsenic Trioxide 1Antilymphocyte Serum 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myelomonocytic, Acute × Idarubicin × Clear all
NCT00003405 2021-10-14

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

Rush University Medical Center

Phase 2 Withdrawn
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT02527174 2017-04-05

VIAC

University of Alberta

Phase 1 Withdrawn
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡